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Developmental dysplasia of the hip (DDH) is not a specific disorder; it is rather a scale of 
overlapping and transforming conditions. It ranges from occult dysplasia seen on ultrasound 
screening of newborns, neonatal hip instability and dislocated hip whether reducible by 
orthopaedic manipulation or not. The hallmark of DDH is acetabular dysplasia—abnormality 
in size, shape or orientation of acetabulum. A thoughtful elucidation regarding DDH is that 
it is ‘a common and preventable cause of childhood disability’ [1]. Complications and conse-
quences of DDH make this time interval much longer, though.
The incidence of many faces of DDH is fortunately distributed: it is reported to be as much 
as 8% for dysplasia, 1–3% for neonatal hip instability and <0.2% for frank dislocation [2–4]. 
These epidemiological data are greatly influenced by both diagnostic criteria and diagnostic 
methods used [5, 6]. They evolve not only due to demographic changes of population, pre-
dominantly through migrations and genetic mixing, but also due to changes in nutrition [7–9].
DDH is not a disease of modern age. It was recognised and described by Hippocrates as a con-
genital dislocation of the hip. Dysplastic hips and presence of false acetabulum were found in 
skeletons from medieval times [10–14].
Present etiological concept of DDH is multifactorial, consisting of endogenous (genetic 
disorders of collagen or collagen-related enzymes, transmembrane G-protein) [15, 16] and 
exogenous factors (related to intrauterine biomechanics, such as breech position and history 
of prior pregnancies, or environmental like birth in a certain season, swaddling technique) 
[17–19]. Breech presentation, positive family history of DDH, female sex, vaginal delivery, 
primiparity and oligohydramnion are usually regarded to as DDH risk factors. Some authors 
include other mechanical intrauterine restrictions (large baby, multiple pregnancy), advanced 
maternal age and delivery-related conditions (post-maturity) [1, 20]. It is worth noting that 
premature birth is not a risk factor for DDH [21]. Risk factors have limited clinical importance, 
however, due to both low sensitivity (10–27% of all infants who have DDH also have any risk 
factor) and low specificity (under 10% of children with risk factors have DDH) [22, 23].
© 2017 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
Historically, there were several crucial events that improved both the diagnosing and treating 
this disease.
 - First, understanding the hip biomechanics, Lorenz in 1895 introduced first successful meth-
od of closed reduction, using plaster cast in extreme abduction for retention [24]. Results 
were immediately supported with new method discovered same year: X-rays, and so the 
Lorenz method became widespread.
 - Then, in 1935, Italian paediatrician Ortolani established a diagnostic manoeuvre used to 
verify present dislocation with audible and sensible ‘click’ [25]. He was the first to recog-
nize the importance of diagnosis of dislocated hip in infants. A systematic screening of 
newborn hips has started.
 - In 1944, Pavlik begun applying the harness as means for keeping dysplastic hips mobile but 
limited to advantageous abduction angles, thus promoting biomechanical stimulation of 
normal hip development [26].
 - Modern operative treatment of acetabular dysplasia begun with Chiari [27] and Salter [28] 
pelvic osteotomy.
 - In 1961, Charnley introduced modern concept of total hip replacement in the treatment of 
osteoarthritis, a common sequela of hip dysplasia in adult age [29].
 - Following the technological improvements, Graf introduced ultrasound as a method for vi-
sualisation of the hip and described diagnostic criteria for assessment of hip dysplasia [30].
 - Finally, with screening data available, Klisic introduced a new name ‘developmental dys-
plasia’ [31].
Basically, there are five very important dilemmas that demarcate the struggle with this rather 
recalcitrant medical condition. Their analysis reflects both the complexity of problem and 
diversity of solutions currently available across the medical practice in the whole world.
1. Screening for hip dysplasia: overlooking versus overtreating
Neonatal hip joint demonstrates significant potential for growth and remodelling. Still, the 
outcome of nonoperative reduction of dislocated femoral head and its safe containment 
within the acetabulum strongly depends on timing. If a treatment begins within first 7 weeks, 
it will be highly successful [32–35] regardless if one or both hips are treated [36]. That is why 
meticulous clinical examination of hips in newborns is mandatory for decades. Establishing 
a diagnosis of DDH after 3 months of age is considered as a late presentation, with estimated 
incidence from 0.02 to 0.2% [37, 38]. It is associated with higher rate of operative treatment, 
worse prognosis and increased healthcare cost [39–43].
Unstable or dislocated hip is usually diagnosed by combined Ortolani-Barlow manoeuvre, 
with satisfactory specificity (>84%) but controversial sensitivity (from 7 to 98% in various stud-
ies) [44]. These clinical signs, however, cannot pinpoint acetabular dysplasia. For that  reason, 
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in some medical systems, an ultrasound screening is also mandatory and universal [8], while 
in others, it is used only in selected, targeted cases [45]. These variations in screening proto-
col are due to economic, organisational reasons, as well as the concern of over diagnosing 
and possible unnecessary treatment [46–48]. Most common ultrasound screening methods are 
according to Graf, Harcke, Terjesen and Suzuki. Data from Austria, UK and Ireland suggest 
that universal ultrasonic screening for DDH reduced both overall average healthcare expenses 
and the need for operative treatment [2, 45, 49–52], although there are different opinions in 
the USA [53].
While very valuable for early detection of hip dislocation, and without any absolute contra-
indications [54] ultrasound in first 2 weeks of life has limited sensitivity to detect clinically 
relevant dysplasia, since a fraction of newborns have underdeveloped but healthy hips—a 
temporarily false positive result [4, 55, 56]. Some authors even suggest that ultrasound in 
first 6 weeks should confirm the diagnosis of DDH only if hip is decentred (Graf III type) or 
dislocated (Graf IV type). For true incidence of hip dysplasia, a correlation of ultrasound data, 
clinical examination and the number of late presented cases requiring operative treatment 
should all be analysed.
Nevertheless, the problem how to discriminate between dysplastic hips and healthy hips still 
remains—ultrasound is too dependent on examiner’s skills, while radiographic criteria are 
usually biased by pelvic rotation [57]. Effective screening for DDH should be characterised 
by low percentage of cases that require surgical intervention, and all of those due to failures 
of nonoperative treatment, rather than due to late detection [49, 58]. In some studies, the 
majority of patients with symptomatic dysplasia in adult age did not meet criteria for selec-
tive ultrasound screening in infant age—they were false negative on clinical examination [59].
2. Neonatal hip instability: nature versus therapy
Like hip dysplasia, neonatal hip instability follows similar diagnostic concerns. This condition 
is diagnosed either by provocative tests (Barlow) or by dynamic ultrasound testing (Harcke 
technique) [60] with substantial reproducibility and accuracy only achieved in combination 
of these methods [40]. On the other hand, failure of recognition and treatment of neonatal hip 
instability can lead to significant hip dysfunction [61].
Neonates are usually born with slight flexion contracture (25–30°), which should spontane-
ously decrease to <20° at 6 weeks, and 7° at 12 weeks. In addition, one should bear in mind 
that majority of hips clinically unstable at birth will resolve spontaneously within first 8 
weeks [62], in some cases until 3 years of age [63]. In other words, specificity of clinical and 
ultrasonic examination improves with growth. This is particularly true for testing if there is 
limited abduction, which meets its peak of reliability as DDH marker at the age between 3 
and 6 months [64].
The relation between abduction position and movements and proper stimulation of dysplastic/
unstable acetabulum to become better is clearly demonstrated, and positioning of legs influ-
ences the outcome of hip development [65]. While wide (double) diapering stimulates beneficial 
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dynamic abduction of both hips, there is also an opposite praxis of swaddling (hips in extension 
and in zero abduction) either due to traditional routine in some parts of the world (Middle East, 
Japan, Native Americans, etc.) [66–68] or for the prevention of excessive crying and promoting 
sleep [69]. It is clear, however, that risk for hip deterioration if legs are kept laced grossly sur-
passes all potential benefits, which are easily achievable by other, less hazardous means.
3. Natural history of DDH: prevention versus operation
We already stated that dysplastic and unstable hips may undergo spontaneous recovery [70]. 
As for the cohort of non-recovering hips, it has been observed that DDH leads to significant 
loss of normal joint function [71]. Dysplastic hips have tendency to evolve over years into 
painful and debilitating osteoarthritis [72–74], while dislocated hips are accompanied with 
short posture and waddling gait throughout life, and if not reduced operatively within the 
first 8 years, painful syndrome may eventually develop [59, 75]. In patients with untreated 
unilateral dislocation, pelvic obliquity deteriorates the distribution of hip force on contralat-
eral hip joint, contributing to degeneration on that side as well, along with further compensa-
tory dysfunctions of trunk and knees [11].
DDH and osteoarthritis share genetic biomechanical etiological aspects [76]. Longitudinal 
studies have revealed that degenerative changes induced by hip dysplasia develop more 
rapidly than in other predisposing conditions [77]. Total hip replacement (THR) is a surgi-
cal procedure that is most often performed in treating symptomatic advanced osteoarthritis, 
especially in younger age [78–82]. The diagnosis of DDH in first-order relative increases a 
chance for THR by the age of 65 [83]. Recent studies show that average hospital cost for pri-
mary THR secondary to DDH is higher than in other cases. Also, the severity of DDH addi-
tionally increases those expenses [79, 84]. If DDH is diagnosed early and the treatment was 
nonoperative, the rate of osteoarthritis at long-term follow-up is twice lower than after open 
reduction [81]. On the other hand, survival rate of dislocated hips that undergone operative 
treatment in infancy including innominate osteotomy was 54% at the age of 45 [85].
4. The follow-up challenge: hip morphology versus function
Since DDH is a kind of ‘moving target’ throughout patient’s life, several assessment protocols 
are in use for follow-up once the diagnosis is established, depending on the kind of interven-
tion (observation, nonoperative or operative procedure), age and complaints. They all have 
the same two prominent characteristics:
(a) Low reliability and inter-observer concordance [86].
(b) Inadequate correlation of functional and radiographic results [87], implying that not all 
radiographically dysplastic/arthritic hip joints are the same, and that more than morpho-
logic factors influence the onset and severity of symptoms.
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Health-related part of elusive term we refer to as ‘quality of life’ (QoL) includes, but is not limited 
to, satisfaction in physical, emotional and social aspects of life. Quality of life with DDH is mostly 
affected by pain, gait disturbance, limited range of motion and leg length discrepancy. These fac-
tors are not independent, they aggravate each other. Patients become regular consumers of vari-
ous healthcare services and products, spending days and money on rehabilitation, usually getting 
weight because of inadequate activity. Several studies demonstrated long-term improvement in 
QoL after THA in patients diagnosed with DDH [88, 89]. Although very important for patient, 
QoL assessment should be primarily used to identify their expectation regarding the type of treat-
ment and should not replace clinical examination and standard diagnostic methods [90, 91].
5. The impact of DDH on healthcare: cause versus effect
Many diseases have been imposing a strong burden to healthcare service on global scale, in 
aspects of organisation, cost and consequences of diagnostic and therapeutic modalities indi-
cated. In a rather long list, one could count in tuberculosis, diabetes, cardiac failure, cancer, 
AiDS and DDH. Most of them share the same characteristic of significant mortality, direct or 
indirect through complications. On the other hand, DDH is among the few exceptions that 
are not directly life threatening but deteriorate the quality of life and/or working ability up to 
great extent and for a long time [92].
Osteoarthritis is one of the major causes of non-cancer pain, impairing daily and social activi-
ties, and carrying a significant economic burden measurable in billions of dollars annually 
[93, 94]. Estimations are that there are more than 4.7 million THA operations done annu-
ally in the whole world, with significant portion due to DDH [95]. Average total expenses of 
THA treatment are about 20,000 euros per patient [17], with great variance. For illustration, in 
Serbian healthcare system, it is less than 10,000 euros using the same modern implants.
In accordance to non-maleficent approach, detailed patient examination and utilisation of all 
diagnostic and therapeutic procedures that are indicated for suspected condition in every patient, 
always leads to better clinical outcome. But in everyday practice, there is usually more than one 
option for every step in patient management. These options sometimes differ not only in side 
effects, reliability, safety or indication requirements but also in technical and financial availabil-
ity. That’s where statistics and economics come to interfere with strictly medical issues. In some 
cases, such as DDH, many factors need to be considered in order to see the whole picture [96–98].
For instance, introduction of ultrasound examination to clinical screening for hip dysplasia 
revealed that some clinically positive cases are false positive, but also vice versa; it brought a frac-
tion of clinically normal, but sonographically dysplastic or lax hips. Since it incurred extra cost 
and organisational effort, subsequent justification had to come from economic studies [45, 68].
Factors that contribute to late diagnosing of DDH include inconsistent implementation of screen-
ing protocol, lack of appropriate awareness of the disease and its complications and insufficient 
training in proper and timely detection of DDH and therapeutic actions [42, 99]. Important but 
often neglected issue in this situation, where operative treatment makes the method of choice, 
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is the involvement of parents (usually mother) in the process of treatment. Mothers stay with 
their child for the whole duration of the treatment—usually for 3–6 months following open 
reduction, with the child immobilised in bed by plaster cast or skin traction, in hospital and/or 
at home for weeks. This is tangled with many new problems involving the patient itself (such as 
feeding, hygiene in the cast, dressing, sleeping, transport), mother (employment status, social 
isolation, existing physical and mental health condition) and the rest of the family (altered daily 
activities) for a long period of time [100]. There is a general lack of information and outpatient 
support about recovering child’s complex needs during that period [101, 102].
Summary
There is considerable diversity in opinions worldwide regarding both diagnostic and thera-
peutic approach to DDH. Besides orthopaedic, many other factors could contribute to it: demo-
graphic, socioeconomic and differences regarding healthcare organisation [5]. Reflecting this 
diversity, in this book authors will present their experience and opinion on several important 
issues regarding DDH: screening for DDH, biomechanical considerations, diagnostic proce-
dures in all age groups, treatment modalities of hip dysplasia and dislocation in childhood, 
and dealing with the consequences in adulthood.
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